Mico BioMed, Rapid Antigen Test Kit Demand Surges... Benefiting from Omicron Response

Rapid Increase in Demand with Expanded Operation of Respiratory Clinics, Hospitals, and Public Health Centers
Starting This Month, Hundreds of Thousands of Tests Supplied Through Domestic Pharmaceutical Distribution Networks
Significant Increase in Exports of Rapid Antigen Test Kits to Japan, Brazil, and Others

[Asia Economy Reporter Hyungsoo Park] MikobioMed, a manufacturer of in vitro diagnostic medical devices, is set to actively supply rapid antigen test kits for COVID-19 experts both domestically and internationally.

Since the 3rd, as quarantine authorities have fully activated the Omicron response quarantine system, the demand for rapid antigen test kits has surged sharply beyond manageable levels.

General citizens, excluding high-risk groups, receive rapid antigen tests instead of PCR tests at screening clinics, respiratory-specialized clinics, and local hospitals and clinics.

MikobioMed will supply hundreds of thousands of doses of its expert-use rapid antigen test kit (VERI-Q COVID-19 Ag Rapid Test) nationwide from this month through the distribution networks of major pharmaceutical companies to public health centers, respiratory-specialized clinics, and local hospitals and clinics.

A company official stated, "In anticipation of the transition to the Omicron quarantine system, inquiries about the supply of rapid antigen test kits flooded in throughout the Lunar New Year holiday," adding, "For efficient quarantine system operation, the demand for expert-use test kits will surge simultaneously with that of self-test kits."

As the Omicron variant rapidly becomes the dominant strain worldwide, MikobioMed is actively responding to the increased overseas demand for rapid antigen test kits in countries such as Brazil and Japan.

The company official added, "Since last year, the Japanese market has given positive evaluations of our product performance," and "From this month, the export scale will expand, and our products will be widely used from educational institutions (elementary, middle, and high schools) to JPGA players."

MikobioMed plans to export millions of doses of rapid antigen test kits annually to Japan, Brazil, and other countries.

This content was produced with the assistance of AI translation services.